| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126390 Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
| 07/01/2004 | US20040126389 Vaccine composition |
| 07/01/2004 | US20040126388 Measurement genome reproduction of virus; linked to reproter compound; high speed screening for Hepatitis virus |
| 07/01/2004 | US20040126386 Mutant proteins; induce immunology response; antitumor agents |
| 07/01/2004 | US20040126383 Administering polyclonal antibody globulin; neutralization antigens; diarrhea therapy |
| 07/01/2004 | US20040126382 Two-step immunization procedure against chlamydia infection |
| 07/01/2004 | US20040126381 Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella |
| 07/01/2004 | US20040126379 Complex containing antibody and cytotoxic compound |
| 07/01/2004 | US20040126373 Administering tumor necrosis factor antibody; restenosis |
| 07/01/2004 | US20040126372 Administering antibodies; respiratory system disorders; cardiovascular disorders; metabolism disorders; anemia; analgesics; liver disorders; skin disorders |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 07/01/2004 | US20040126362 Anticancer agents; leukemia ; therapy, prevent of metabolism diseases |
| 07/01/2004 | US20040126357 Lectin compositions and methods for modulating an immune response to an antigen |
| 07/01/2004 | DE10259053A1 Oral vaccine for vaccination against e.g. cancer comprises combination of antigen, especially tumor antigen, and gastric acidity reducing agent, e.g. antacid, H2-antagonist or proton pump inhibitor |
| 07/01/2004 | CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2779684A1 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | CA2509902A1 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 07/01/2004 | CA2509825A1 Antagonists for human prolactin |
| 07/01/2004 | CA2509678A1 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | CA2508825A1 Vaccine for fish cold-water disease |
| 07/01/2004 | CA2507915A1 Recombinant viral-based malaria vaccines |
| 06/30/2004 | EP1433849A1 NOVEL POLYPEPTIDE, DNA THEREOF AND USE OF THE SAME |
| 06/30/2004 | EP1432821A2 A method for the early detection of cancer |
| 06/30/2004 | EP1432814A2 Antimicrobial methods and materials |
| 06/30/2004 | EP1432792A2 Histone deacetylase 9 |
| 06/30/2004 | EP1432788A2 Live attenuated salmonella strains for producing vaccines |
| 06/30/2004 | EP1432738A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 06/30/2004 | EP1432736A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 06/30/2004 | EP1432735A2 Antagonistic anti-htnfsf13b human antibodies |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1432448A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 06/30/2004 | EP1432446A2 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 06/30/2004 | EP1432445A2 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 06/30/2004 | EP1432444A2 Anti-a-beta antibodies |
| 06/30/2004 | EP1432443A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 06/30/2004 | EP1432442A2 Vaccine |
| 06/30/2004 | EP1432441A2 Use of hmgb1 for the activation of dendritic cells |
| 06/30/2004 | EP1432440A2 Adjuvants for nucleic acid vaccines |
| 06/30/2004 | EP1432438A2 Use of rank antagonists to treat cancer |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP1432418A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 06/30/2004 | EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 06/30/2004 | EP1054688B1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
| 06/30/2004 | EP1032418B1 Compact epstein-barr virus replicons |
| 06/30/2004 | EP1009421B1 Compositions for enhanced wound healing |
| 06/30/2004 | EP0848756B1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 06/30/2004 | EP0690722B1 Composition and method for reducing toxicity of biologically-active factors |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | EP0584167B1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 06/30/2004 | EP0564532B1 Polypeptides derived from proteins of the hepatitis c virus |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509328A Use of opg ligand to modulate immune response |
| 06/30/2004 | CN1509188A Immunoconjugates made of egg-yolk antibiodies (IGY), production and use thereof in diagnoses and therapy |
| 06/30/2004 | CN1509187A Cytotoxic CD44 antibody immunoconjugates |
| 06/30/2004 | CN1509166A Liposome composition for improved intracellular delivery of therapeutic agent |
| 06/30/2004 | CN1508155A Anti CD52 monoclonal antibody, coding sequence and use thereof |
| 06/30/2004 | CN1507916A Compositions comprising neisseria meningitidis antigens from serogroups B and C, and other antigens |
| 06/30/2004 | CN1155710C Recombinant herpesvirus with the use of gB Gene promoter |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155707C Vaccines for plague |
| 06/30/2004 | CN1155620C Thioether conjugates |
| 06/30/2004 | CN1155618C PEG-interferon conjugates |
| 06/30/2004 | CN1155408C Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 06/30/2004 | CN1155407C Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756493 A polypeptide of neisseria spp, e.g, of neisseria gonorrhoeae |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756477 Comprise breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions |
| 06/29/2004 | US6756361 Overcoming antibiotic resistance |
| 06/29/2004 | US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects |
| 06/29/2004 | US6756041 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/29/2004 | US6756040 For the prevention of haemophilus influenzae type b (hib) infections; especially multivalent vaccines |
| 06/29/2004 | US6756038 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 06/29/2004 | US6756036 Methods for treating cancer using PSCA antibodies and fragments thereof |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2276570C Method of pcr testing of pooled blood samples |
| 06/29/2004 | CA2135192C Vaccinal fluid water-in-oil emulsions containing a metabolizable oil |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053487A1 METHOD OF DIAGNOSIS,TREATMENT AND USEFUL AGENTS FOR CONDITIONS CHARACTERISED BY MODULATION IN THE LEVEL OF ACTIVIN βC |
| 06/24/2004 | WO2004053454A2 Methods for detecting invasion of a cell |
| 06/24/2004 | WO2004053100A2 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same |
| 06/24/2004 | WO2004053095A2 In situ maturation of dendritic cells |
| 06/24/2004 | WO2004053086A2 Plasmodium falciparum antigens and methods of use |
| 06/24/2004 | WO2004053072A2 Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 06/24/2004 | WO2004053066A2 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 06/24/2004 | WO2004053064A2 Engineered fab'fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs |
| 06/24/2004 | WO2004053056A2 Nanoparticle-based vaccine delivery system containing adjuvant |
| 06/24/2004 | WO2004052933A2 Peptide oligomers for use as hiv vaccines |
| 06/24/2004 | WO2004052925A2 Actinobacillus pleuropneumoniae virulence genes |
| 06/24/2004 | WO2004052922A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 06/24/2004 | WO2004052920A2 Conversion of apoptotic proteins |
| 06/24/2004 | WO2004052396A1 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 06/24/2004 | WO2004052395A1 L2-peptide of the human papillomavirus associated with virus-like particles |
| 06/24/2004 | WO2004052394A1 Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria |
| 06/24/2004 | WO2004052393A1 Coccidial vaccine and methods of making and using same |